Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 21:4:605-10.
doi: 10.2147/opth.s10992.

Topical administration of adrenergic receptor pharmaceutics and nerve growth factor

Jena J Steinle  1
Affiliations

Topical administration of adrenergic receptor pharmaceutics and nerve growth factor

Jena J Steinle. Clin Ophthalmol. .

Abstract

Topical application of nerve growth factor (NGF) and adrenergic receptor pharmaceutics are currently in use for corneal ulcers and glaucoma. A recent interest in the neuroprotective abilities of NGF has led to a renewed interest in NGF as a therapeutic for retinal and choroidal diseases. NGF can promote cell proliferation through actions of the TrkA receptor or promote apoptosis through receptor p75(NTR). This understanding has led to novel interest in the role of NGF for diseases of the posterior eye. The role of beta-adrenergic receptor agonists and antagonists for treatments of glaucoma, diabetic retinopathy, and their potential mechanisms of action, are still under investigation. This review discusses the current knowledge and applications of topical NGF and adrenergic receptor drugs for ocular disease.

Keywords: NGF; cornea; glaucoma; retina; α-adrenergic receptor agents; β-adrenergic receptor agents.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Dechant G, Neumann H. Neurotrophins. Adv Exp Med Biol. 2002;513:303–334. - PubMed
    1. Cowan WM, Hamburger V, Levi-Montalcini R. The path to the discovery of nerve growth factor. Annu Rev Neurosci. 2001;24:551–600. - PubMed
    1. Levi-Montalcini R, Angeletti PU. Nerve growth factor. Physiol Rev. 1968;48(3):534–569. - PubMed
    1. de la Rosa EJ, de Pablo F. Cell death in early neural development: beyond the neurotrophic theory. Trends Neurosci. 2000;23(10):454–458. - PubMed
    1. Hill CE, Jelinek H, Hendry IA, et al. Destruction by anti-NGF of autonomic, sudomotor neurones and subsequent hyperinnervation of the foot pad by sensory fibers. J Neurosci Res. 1988;19:474–482. - PubMed